📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OncoMark

1.1 - Company Overview

OncoMark Logo

OncoMark

Headquarter: Ireland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of companion diagnostic tests for cancer patient stratification. An Irish UCD spin-out, the company develops diagnostics to support cancer drug development, enabling pharmaceutical companies to select patients for whom a drug may be particularly effective, and tests that can also be used during clinical trials to help reduce the numbers of patients required.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OncoMark

IMGM Laboratories Logo

IMGM Laboratories

HQ: Germany Website
  • Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IMGM Laboratories company profile →
Ultima Genomics Logo

Ultima Genomics

HQ: United States Website
  • Description: Provider of a low-cost sequencing platform and related workflows, including the UG 100™ high-throughput system using a 200mm open silicon wafer with built-in automation; ppmSeq™ for rare event detection at one part per million for liquid biopsies and MRD; large-scale single-cell and spatial sequencing workflows; RNA-Seq for gene expression and isoform analysis; and genome-wide methylation sequencing compatible with standard tools.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ultima Genomics company profile →
Precision Biomonitoring Logo

Precision Biomonitoring

HQ: Canada Website
  • Description: Provider of biotechnology and research specializing in various types of DNA and testing services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precision Biomonitoring company profile →
Singleron Logo

Singleron

HQ: China Website
  • Description: Provider of clinical diagnosis, health management, and drug development products and services, dedicated to applying single cell analysis techniques. Holds a worldwide exclusive IP license from Yale University for a uniquely designed microfluidic single cell processing device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Singleron company profile →
Genova Diagnostics Logo

Genova Diagnostics

HQ: United States Website
  • Description: Provider of global specialty clinical laboratory testing using a systems approach to support personalized treatment and prevention of chronic disease. Offers diagnostic profiles including GI Effects stool analysis; NutrEval; Metabolomix+ urine-based nutritional biomarkers (optional bloodspot, buccal swab); Methylation Panel (plasma metabolites, genetic SNPs); Endo+ hormone assessment; and Adrenocortex Stress Profile of the HPA axis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genova Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OncoMark

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OncoMark

2.2 - Growth funds investing in similar companies to OncoMark

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OncoMark

4.2 - Public trading comparable groups for OncoMark

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OncoMark

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OncoMark

What does OncoMark do?

OncoMark is a provider of companion diagnostic tests for cancer patient stratification. An Irish UCD spin-out, the company develops diagnostics to support cancer drug development, enabling pharmaceutical companies to select patients for whom a drug may be particularly effective, and tests that can also be used during clinical trials to help reduce the numbers of patients required.

Who are OncoMark's competitors?

OncoMark's competitors and similar companies include IMGM Laboratories, Ultima Genomics, Precision Biomonitoring, Singleron, and Genova Diagnostics.

Where is OncoMark headquartered?

OncoMark is headquartered in Ireland.

How many employees does OncoMark have?

OncoMark has 1,000 employees 🔒.

When was OncoMark founded?

OncoMark was founded in 2010 🔒.

What sector and industry vertical is OncoMark in?

OncoMark is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OncoMark

Who are the top strategic acquirers in OncoMark's sector and industry

Top strategic M&A buyers and acquirers in OncoMark's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OncoMark?

Top strategic M&A buyers groups and sectors for OncoMark include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OncoMark's sector and industry vertical

Which are the top PE firms investing in OncoMark's sector and industry vertical?

Top PE firms investing in OncoMark's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OncoMark's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OncoMark's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OncoMark's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OncoMark include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OncoMark's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OncoMark?

The key public trading comparables and valuation benchmarks for OncoMark include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OncoMark for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OncoMark with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OncoMark's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OncoMark with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OncoMark's' sector and industry vertical?

Access recent funding rounds and capital raises in OncoMark's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OncoMark